Community-reported Olanzapine side effects:
Add Your Side Effect to the Community Database
Help Community - Describe Your Olanzapine Side Effect Episode
Have You dealt with a Olanzapine side effect? Share your experience
Review Olanzapine Safety Reports submitted to FDA
Total Olanzapine reports: 279.Olanzapine FDA safety alerts: 2002 2004 2005 .
Reported deaths: 66 Reported hospitalizations: 127.
Take Olanzapine Side Effects Survey, Discuss Olanzapine with others
FDA Reported Olanzapine Side Effects: weight increased, overdose, death, neuroleptic malignant syndrome, pulmonary embolism, somnolence, neutropenia, diabetes mellitus non-insulin-dependent, dyspnoea, diabetes mellitus insulin-dependent, deep vein thrombosis.
More About Olanzapine.
If you have questions about Olanzapine, you can ask a Health Expert or Ask Patient Community about Olanzapine.
Showing 1-100 of 279 Next >
Olanzapine Side Effects Report #5365424-7Physician from SWEDEN reported OLANZAPINE problem on June 11, 2007. Female patient, 43 years of age, was diagnosed with psychotic disorder and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: burns third degree, dyspnoea, intentional self-injury, oxygen saturation decreased, pulmonary oedema, renal failure. OLANZAPINE dosage: 10 MG, DAILY (1/D). Patient was hospitalized. Patient died on 06/01/2007.
Olanzapine Side Effects Report #5369226-7
OLANZAPINE problem was reported by a Physician from CROATIA (local name: Hrvatska) on June 15, 2007. Male patient, 44 years of age, was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: brain oedema, hyperglycaemia, hyponatraemia, pancreatitis haemorrhagic. OLANZAPINE dosage: unknown. During the same period patient was treated with PAROXETINE, FLUPHENAZINE, HALOPERIDOL INTENSOL. Patient was hospitalized. Patient died.
Olanzapine Side Effects Report #5369256-5
Physician from HUNGARY reported OLANZAPINE problem on June 15, 2007. Female patient, 69 years of age, was diagnosed with bipolar disorder, depression and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: hypoglycaemic coma. OLANZAPINE dosage: 2.5 MG, DAILY (1/D). During the same period patient was treated with REXETIN. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5370573-3
OLANZAPINE problem was reported by a Physician from PANAMA on June 20, 2007. Male patient, 27 years of age, was diagnosed with bipolar disorder and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: metabolic syndrome. OLANZAPINE dosage: 10 MG, DAILY (1/D). Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5373934-1
Physician from ITALY reported OLANZAPINE problem on June 15, 2007. Male patient, 25 years of age, was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, pyrexia, staphylococcal infection. OLANZAPINE dosage: 20 MG, DAILY (1/D). During the same period patient was treated with CLONAZEPAM, HALOPERIDOL, LORAZEPAM. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5045024-9
OLANZAPINE problem was reported by a Consumer or non-health professional from UNITED STATES on June 14, 2006. Male patient, 29 years of age, weighting 259.9 lb, was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, diabetes mellitus, thirst, weight increased. OLANZAPINE dosage: 10 MG, ORAL. During the same period patient was treated with RISPERIDONE, HALDOL, PROLIXIN, COGENTIN. Patient was hospitalized. Patient died on 02/21/2004.
Olanzapine Side Effects Report #5048637-3
Consumer or non-health professional from UNITED KINGDOM reported OLANZAPINE problem on June 14, 2006. Female patient, weighting 180.8 lb, was diagnosed with psychotic disorder and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: atrioventricular extrasystoles, balance disorder, dizziness, dysarthria. OLANZAPINE dosage: 5 MG, ORAL. Patient recovered.
Olanzapine Side Effects Report #5048734-2
OLANZAPINE problem was reported by a Physician from HUNGARY on June 15, 2006. Male patient, 33 years of age, was diagnosed with psychotic disorder and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism. OLANZAPINE dosage: 10 MG, 2/D, INTRAMUSCULAR. During the same period patient was treated with EDNYT, HALOPERIDOL, INSULATARD NPH, ACTRAPID. Patient died on 05/27/2006.
Olanzapine Side Effects Report #5048788-3
Consumer or non-health professional from UNITED KINGDOM reported OLANZAPINE problem on June 14, 2006. Female patient, 60 years of age, was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: leukocytoclastic vasculitis, mania. OLANZAPINE dosage: unknown. During the same period patient was treated with EPILIM, CHLORPROMAZINE, CLONAZEPAM. Patient recovered.
Olanzapine Side Effects Report #5052107-6
OLANZAPINE problem was reported by a Consumer or non-health professional from DENMARK on June 23, 2006. Male patient, 58 years of age, weighting 160.9 lb, was diagnosed with anxiety and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: fatigue, weight increased, white blood cell count increased. OLANZAPINE dosage: unknown. During the same period patient was treated with CITALOPRAM HYDROBROMIDE, FLUPENTIXOL DIHYDROCHLORIDE. Patient recovered.
Olanzapine Side Effects Report #5055335-9
Physician from AUSTRALIA reported OLANZAPINE problem on June 28, 2006. Female patient, 43 years of age, was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: breast cancer female. OLANZAPINE dosage: 10MG,. Patient recovered.
Olanzapine Side Effects Report #5061942-X
OLANZAPINE problem was reported by a Pharmacist from JAPAN on July 04, 2006. Female patient, 44 years of age, was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: appendicitis, sepsis. OLANZAPINE dosage: unknown. Patient recovered.
Olanzapine Side Effects Report #5062462-9
Physician from GREECE reported OLANZAPINE problem on July 03, 2006. Male patient, 29 years of age, was diagnosed with mental disorder and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: road traffic accident. OLANZAPINE dosage: 10 MG, DAILY (1/D), ORAL. During the same period patient was treated with LITHIUM. Patient died on 01/01/2005.
Olanzapine Side Effects Report #5062518-0
OLANZAPINE problem was reported by a Health Professional from JAPAN on July 03, 2006. Female patient, weighting 84.88 lb, was diagnosed with schizophrenia, paranoid type and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: completed suicide, injury asphyxiation. OLANZAPINE dosage: 5 MG, 3/D, ORAL. During the same period patient was treated with RISPERDAL, LORAZEPAM, AMOBAN, NITRAZEPAM, DORAL, CELMANIL, ARTANE. Patient died on 06/24/2006.
Olanzapine Side Effects Report #5068053-8
Physician from GREECE reported OLANZAPINE problem on July 13, 2006. Female patient, 56 years of age, weighting 154.3 lb, was diagnosed with schizophrenia and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia. OLANZAPINE dosage: 5 MG, 4/D ORAL. During the same period patient was treated with DIAZEPAM, VITAMIN B 1. Patient recovered.
Olanzapine Side Effects Report #5068261-6
OLANZAPINE problem was reported by a Physician from CROATIA (local name: Hrvatska) on July 10, 2006. Female patient, 33 years of age, was diagnosed with mental disorder and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: coma, epilepsy, grand mal convulsion, neuroleptic malignant syndrome, renal failure, rhabdomyolysis, tachycardia. OLANZAPINE dosage: 20 MG DAILY (1/D), ORAL. During the same period patient was treated with FLUFENAZIN. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5068381-6
Physician from BELGIUM reported OLANZAPINE problem on July 13, 2006. Male patient, 66 years of age, weighting 165.3 lb, was diagnosed with mania and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, coma, grand mal convulsion, salivary hypersecretion. OLANZAPINE dosage: 10 MG DAILY (1/D), INTRAMUSCULAR. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5068953-9
OLANZAPINE problem was reported by a Physician from INDIA on July 17, 2006. Male patient, 31 years of age, was diagnosed with schizophrenia and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: lower respiratory tract infection, neutropenia, prescribed overdose, psychotic disorder, white blood cell count decreased. OLANZAPINE dosage: unknown. During the same period patient was treated with RISPERIDONE, CLOZAPINE, CEPHALOSPORINS AND RELATED SUBSTANCES, QUINOLONE ANTIBACTERIALS. Patient recovered.
Olanzapine Side Effects Report #5069016-9
Physician from GREECE reported OLANZAPINE problem on July 19, 2006. Male patient, 29 years of age, was diagnosed with mental disorder and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: road traffic accident. OLANZAPINE dosage: 10 MG, DAILY (1/D), ORAL. During the same period patient was treated with LITHIUM. Patient died on 01/01/2005.
Olanzapine Side Effects Report #5069031-5
OLANZAPINE problem was reported by a Physician from GREECE on July 10, 2006. Male patient, 60 years of age, weighting 154.3 lb, was diagnosed with bipolar disorder and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: alcohol use, hepatic failure, renal failure. OLANZAPINE dosage: unknown. During the same period patient was treated with LITHIUM. Patient died on 07/21/2005.
Olanzapine Side Effects Report #5071760-4
Physician from RUSSIAN FEDERATION reported OLANZAPINE problem on July 19, 2006. Male patient, 73 years of age, was diagnosed with schizophrenia, paranoid type and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: completed suicide, prescribed overdose. OLANZAPINE dosage: 10 MG, 3/D, ORAL. Patient died on 07/03/2006.
Olanzapine Side Effects Report #5072795-8
OLANZAPINE problem was reported by a Physician from GREECE on July 24, 2006. Male patient, 66 years of age, weighting 191.8 lb, was diagnosed with bipolar disorder and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: hepatic failure, renal failure. OLANZAPINE dosage: unknown. During the same period patient was treated with LITHIUM. Patient died on 07/21/2005.
Olanzapine Side Effects Report #5072797-1
Physician from ITALY reported OLANZAPINE problem on June 28, 2006. Female patient, 25 years of age, was diagnosed with psychotic disorder and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: agitation, arrhythmia, cardiopulmonary failure, dyskinesia, dyspnoea, extrapyramidal disorder, eye disorder, foaming at mouth. OLANZAPINE dosage: unknown. During the same period patient was treated with DIAZEPAM, AKINETON. Patient died on 01/11/2002.
Olanzapine Side Effects Report #5078414-9
OLANZAPINE problem was reported by a Physician from SPAIN on July 19, 2006. Female patient, 26 years of age, was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: amnesia, aphasia, blood sodium increased, cognitive disorder, disturbance in attention, electroencephalogram abnormal, epstein-barr virus antibody positive, haemoglobin decreased, lipoma. OLANZAPINE dosage: unknown. During the same period patient was treated with ALPRAZOLAM, DIPOTASSIUM CLORAZEPATE, HALOPERIDOL. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5078425-3
Physician from HUNGARY reported OLANZAPINE problem on July 21, 2006. Male patient, 23 years of age, was diagnosed with schizophrenia and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: thrombosis. OLANZAPINE dosage: 5 MG, DAILY (1/D), ORAL. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5078430-7
OLANZAPINE problem was reported by a Physician from GREECE on July 18, 2006. Female patient was diagnosed with bipolar disorder and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. OLANZAPINE dosage: 10 MG, DAILY (1/D), ORAL. Patient died on 02/01/2006.
Olanzapine Side Effects Report #5078914-1
Consumer or non-health professional from UNITED STATES reported OLANZAPINE problem on July 21, 2006. Male patient, 41 years of age, was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus, loss of consciousness. OLANZAPINE dosage: unknown. Patient recovered.
Olanzapine Side Effects Report #5079895-7
OLANZAPINE problem was reported by a Physician from MEXICO on July 26, 2006. Male patient, 40 years of age, was diagnosed with major depression and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: haematuria, pruritus, swelling, weight increased. OLANZAPINE dosage: unknown. During the same period patient was treated with PROZAC, ZYPREXA, AMITRIPTYLINE. Patient recovered.
Olanzapine Side Effects Report #5080114-6
Pharmacist from UNITED STATES reported OLANZAPINE problem on July 27, 2006. Female patient, 66 years of age, was diagnosed with schizophrenia and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: neuroleptic malignant syndrome. OLANZAPINE dosage: unknown. During the same period patient was treated with ZOLPIDEM TARTRATE, VALPROIC ACID, MIRTAZAPINE, TRAZODONE, QUETIAPINE FUMARATE, BENZATROPINE MESYLATE, DANTROLENE. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5081604-2
OLANZAPINE problem was reported by a Physician from UNITED KINGDOM on July 31, 2006. Female patient, weighting 4.19 lb, was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: premature baby, small for dates baby, trisomy 21. OLANZAPINE dosage: unknown. Patient recovered.
Olanzapine Side Effects Report #5081622-4
Physician from GREECE reported OLANZAPINE problem on Aug 01, 2006. Female patient was diagnosed with bipolar disorder and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident, treatment noncompliance. OLANZAPINE dosage: 10 MG, DAILY (1/D), ORAL. During the same period patient was treated with FRUMIL, SELECTOL, REMERON. Patient died on 12/01/2005.
Olanzapine Side Effects Report #5084975-6
OLANZAPINE problem was reported by a Consumer or non-health professional from UNITED STATES on July 27, 2006. Male patient, 48 years of age, weighting 285.1 lb, was diagnosed with bipolar disorder and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: abdominal distension, abdominal pain upper, blood pressure decreased, cardiac stress test abnormal, chest pain, dyspnoea, fatigue, flatulence, gastrointestinal disorder. OLANZAPINE dosage: ORAL ; 15 MG DAILY (1/D) ; 10 MG DAILY (1/D) ORAL ; 7.5 MG DAILY (1/D) ORAL ; 10 MG DAILY (1/D)ORAL. During the same period patient was treated with VALPROIC ACID, GUIAFENESIN W, ACETAMINOPHEN, BACTRIM DS. Patient recovered.
Olanzapine Side Effects Report #5084976-8
Consumer or non-health professional from UNITED STATES reported OLANZAPINE problem on July 26, 2006. Male patient, weighting 250.0 lb, was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus, hepatitis viral. OLANZAPINE dosage: 5 MG ORAL. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5086106-5
OLANZAPINE problem was reported by a Physician from GERMANY on July 31, 2006. Female patient, 34 years of age, was diagnosed with schizophrenia and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: brain damage. OLANZAPINE dosage: 20 MG, DAILY (1/D). During the same period patient was treated with CITALOPRAM HYDROBROMIDE. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5086111-9
Physician from HUNGARY reported OLANZAPINE problem on Aug 03, 2006. Male patient, 23 years of age, was diagnosed with schizophrenia and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: thrombosis. OLANZAPINE dosage: 5 MG, DAILY 1/D), ORAL. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5087476-4
OLANZAPINE problem was reported by a Pharmacist from UNITED STATES on Aug 23, 2006. Male patient, 36 years of age, weighting 211.0 lb, was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus. OLANZAPINE dosage: 30 MG HS PO. Patient recovered.
Olanzapine Side Effects Report #5087907-X
Pharmacist from UNITED STATES reported OLANZAPINE problem on Aug 23, 2006. Female patient, 46 years of age, weighting 166.0 lb, was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: weight increased. OLANZAPINE dosage: 20 MG 9 AM PO. Patient recovered.
Olanzapine Side Effects Report #5088615-1
OLANZAPINE problem was reported by a Health Professional from AUSTRALIA on July 31, 2006. Male patient, 27 years of age, was diagnosed with schizophrenia and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: cyanosis, dyspnoea, loss of consciousness, therapeutic agent toxicity, vomiting. OLANZAPINE dosage: 20 MG, EACH EVENING, ORAL. During the same period patient was treated with FLUVOXAMINE MALEATE, VALPROATE, CLOZAPINE, ZUCLOPENTHIXOL. Patient was hospitalized. Patient died on 02/26/2000.
Olanzapine Side Effects Report #5088697-7
Physician from AUSTRALIA reported OLANZAPINE problem on Aug 07, 2006. Female patient, 70 years of age, was diagnosed with depression and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction. OLANZAPINE dosage: unknown. During the same period patient was treated with MIRTAZAPINE, OXAZEPAM. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5089123-4
OLANZAPINE problem was reported by a Health Professional from JAPAN on July 31, 2006. Female patient, 58 years of age, was diagnosed with schizophrenia, paranoid type and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, polydipsia. OLANZAPINE dosage: unknown. During the same period patient was treated with RISPERDAL, CHLORPROMAZINE, TEGRETOL, VEGETAMIN A, NITRAZEPAM, ARTANE. Patient recovered.
Olanzapine Side Effects Report #5089566-9
Consumer or non-health professional from UNITED STATES reported OLANZAPINE problem on Aug 01, 2006. Female patient, weighting 280.0 lb, was diagnosed with depression and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus non-insulin-dependent, hepatitis viral, hypertension, metabolic disorder, weight increased. OLANZAPINE dosage: unknown. During the same period patient was treated with SEROQUEL, RISPERIDONE, DEPAKOTE, WELLBUTRIN, PROZAC, INDERAL, DIURIL. Patient recovered.
Olanzapine Side Effects Report #5089628-6
OLANZAPINE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 07, 2006. Male patient, weighting 349.9 lb, was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, diabetes mellitus, metabolic disorder, renal failure acute, rhabdomyolysis, vision blurred, weight increased. OLANZAPINE dosage: 10 MG, 2/D. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5090761-3
Physician from AUSTRALIA reported OLANZAPINE problem on Aug 08, 2006. Male patient, 58 years of age, was diagnosed with hypomania and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, treatment noncompliance. OLANZAPINE dosage: 15 MG. During the same period patient was treated with VALPROATE, LITHIUM. Patient died on 08/01/2006.
Olanzapine Side Effects Report #5091064-3
OLANZAPINE problem was reported by a Health Professional from SPAIN on Aug 22, 2006. Male patient, 28 years of age, was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: poisoning, suicide attempt. OLANZAPINE dosage: unknown. During the same period patient was treated with CLOTIAPINE, LORAZEPAM, TOPIRAMATE, CARBAMAZEPINE. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5091918-8
Physician from JAPAN reported OLANZAPINE problem on Aug 09, 2006. Female patient, weighting 84.88 lb, was diagnosed with schizophrenia, paranoid type and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: completed suicide, injury asphyxiation. OLANZAPINE dosage: 5 MG, 3/D, ORAL. During the same period patient was treated with RISPERDAL, LORAZEPAM, AMOBAN, NITRAZEPAM, DORAL, CELMANIL, ARTANE. Patient died on 06/24/2006.
Olanzapine Side Effects Report #5093226-8
OLANZAPINE problem was reported by a Pharmacist from UNITED STATES on Aug 29, 2006. Male patient, 63 years of age, was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: depressed level of consciousness, myoclonus, somnolence. OLANZAPINE dosage: unknown. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5094166-0
Physician from JAPAN reported OLANZAPINE problem on Aug 11, 2006. Female patient, 68 years of age, was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, disease progression, white blood cell count decreased. OLANZAPINE dosage: 5 MG, DAILY (1/D), ORAL. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5096394-7
OLANZAPINE problem was reported by a Physician from RUSSIAN FEDERATION on Aug 18, 2006. Male patient, 73 years of age, weighting 147.7 lb, was diagnosed with schizophrenia, paranoid type and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: completed suicide. OLANZAPINE dosage: 10 MG, 2/D, ORAL. During the same period patient was treated with HALOPERIDOL, CHLOPROMAZINE, CLOZAPINE, TRIFLUOPERAZINE. Patient died on 07/03/2006.
Olanzapine Side Effects Report #5102953-5
Physician from JAPAN reported OLANZAPINE problem on Aug 17, 2006. Female patient, 47 years of age, weighting 193.1 lb, was diagnosed with schizophrenia, disorganised type and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: aspartate aminotransferase increased, feeling abnormal, loss of consciousness. OLANZAPINE dosage: 10 MG, DAILY (1/D), ORAL. During the same period patient was treated with HIBERNA, ARTANE, AKINETON, RIVOTRIL, ISONIAZID, RISPERDAL, PANTOSIN, MAGNESIUM OXIDE. Patient recovered.
Olanzapine Side Effects Report #5102955-9
OLANZAPINE problem was reported by a Physician from JAPAN on Aug 23, 2006. Female patient, 50 years of age, weighting 158.7 lb, was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: apallic syndrome, breast mass, cardio-respiratory arrest, chronic sinusitis, hypoxia, inappropriate antidiuretic hormone secretion, neuroleptic malignant syndrome, polydipsia, pyrexia. OLANZAPINE dosage: 20 MG, DAILY (1/D), ORAL. During the same period patient was treated with RISPERDAL, AKINETON, ARTANE, PAXIL, ALPRAZOLAM, ACINON, DEPAS. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5104382-7
Pharmacist from UNITED STATES reported OLANZAPINE problem on Sept 08, 2006. Female patient, 28 years of age, weighting 134.0 lb, was diagnosed with schizophrenia, paranoid type and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, liver function test abnormal. OLANZAPINE dosage: 15MG QHS PO. During the same period patient was treated with ACETAMINOPHEN, MAALOX FAST BLOCKER, MILK OF MAGNESIA. Patient recovered.
Olanzapine Side Effects Report #5104629-7
OLANZAPINE problem was reported by a Physician from UNITED KINGDOM on Aug 30, 2006. Female patient, 41 years of age, was diagnosed with psychotic disorder and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: acute stress disorder, alcohol use, overdose, somnolence. OLANZAPINE dosage: 80 MG, ORAL. During the same period patient was treated with ALCOHOL, PAROXETINE. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5104635-2
Pharmacist from JAPAN reported OLANZAPINE problem on Aug 29, 2006. Female patient, 44 years of age, weighting 134.5 lb, was diagnosed with schizophrenia and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: appendicitis, gangrene, peritonitis, platelet count decreased, sepsis. OLANZAPINE dosage: 10 MG, 2/D, ORAL. During the same period patient was treated with DORAL. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5104681-9
OLANZAPINE problem was reported by a Physician from UNITED STATES on Sept 12, 2006. Male patient, weighting 221.0 lb, was diagnosed with abnormal behaviour and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: apnoea, convulsion, resuscitation, skin discolouration. OLANZAPINE dosage: 7.5 MG TWICE A DAY BY MOUTH. Patient died on 06/15/2006.
Olanzapine Side Effects Report #5106167-4
Physician from JAPAN reported OLANZAPINE problem on Aug 25, 2006. Female patient, 50 years of age, weighting 158.7 lb, was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: apallic syndrome, breast mass, cardio-respiratory arrest, chronic sinusitis, gastrostomy, inappropriate antidiuretic hormone secretion, malaise, mutism, neuroleptic malignant syndrome. OLANZAPINE dosage: 20 MG, DAILY (1/D), ORAL. During the same period patient was treated with RISPERDAL. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5106172-8
OLANZAPINE problem was reported by a Physician from GUATEMALA on Aug 30, 2006. Female patient, 28 years of age, was diagnosed with conversion disorder and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, hypotonia. OLANZAPINE dosage: 5 MG, 2/D, ORAL. During the same period patient was treated with CLONAZEPAM. Patient died on 08/22/2006.
Olanzapine Side Effects Report #5109703-7
Physician from GREECE reported OLANZAPINE problem on Sept 04, 2006. Female patient was diagnosed with bipolar disorder and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. OLANZAPINE dosage: 10 MG, DAILY (1/D), ORAL. During the same period patient was treated with FRUMIL, SELECTOL, REMERON. Patient died on 12/01/2005.
Olanzapine Side Effects Report #5109717-7
OLANZAPINE problem was reported by a Physician from GREECE on Sept 06, 2006. Male patient, 57 years of age, weighting 191.8 lb, was diagnosed with bipolar disorder and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: alcohol use, asthenia, blood iron decreased, cyanosis central, dehydration, heart rate increased, hepatic failure, hypotension. OLANZAPINE dosage: 10 MG, DAILY (1/D), ORAL. During the same period patient was treated with LITHIUM. Patient was hospitalized. Patient died on 07/21/2005.
Olanzapine Side Effects Report #5113935-1
Physician from JAPAN reported OLANZAPINE problem on Sept 06, 2006. Female patient, 50 years of age, weighting 158.7 lb, was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: apallic syndrome, breast mass, cardio-respiratory arrest, chronic sinusitis, depressed level of consciousness, inappropriate antidiuretic hormone secretion, nervous system disorder, neuroleptic malignant syndrome, pyrexia. OLANZAPINE dosage: unknown. During the same period patient was treated with RISPERDAL, AKINETON, ARTANE, PAXIL, ALPRAZOLAM, NIZATIDINE, DEPAS. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5117558-X
OLANZAPINE problem was reported by a Physician from GREECE on Sept 12, 2006. Female patient, 37 years of age, weighting 158.7 lb, was diagnosed with bipolar disorder, depression and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: electrocardiogram qt prolonged, lipoma. OLANZAPINE dosage: 20 MG, DAILY (1/D), ORAL. During the same period patient was treated with LADOSE, MELITHIN, NEURONTIN. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5117707-3
Physician from GERMANY reported OLANZAPINE problem on Sept 05, 2006. Female patient, 22 years of age, was diagnosed with anxiety and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: anxiety, oculogyration. OLANZAPINE dosage: 2.5 MG,. During the same period patient was treated with PAROXETINE, LITHIUM. Patient recovered.
Olanzapine Side Effects Report #5117829-7
OLANZAPINE problem was reported by a Physician from MEXICO on Sept 05, 2006. Male patient, 40 years of age, was diagnosed with major depression and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: anxiety, arthralgia, blood testosterone decreased, fear, haemorrhoidal haemorrhage, myalgia, paranoia. OLANZAPINE dosage: unknown. During the same period patient was treated with ZYPREXA, PROZAC, AMITRIPTYLINE, EFFEXOR, LEXOTAN, CLONAZEPAM, SERTRALINE. Patient recovered.
Olanzapine Side Effects Report #5117918-7
Consumer or non-health professional from HUNGARY reported OLANZAPINE problem on Sept 06, 2006. Male patient, 41 years of age, weighting 165.3 lb, was diagnosed with schizophrenia and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: hepatic failure. OLANZAPINE dosage: 5 MG, DAILY (1/D); ORAL. Patient recovered.
Olanzapine Side Effects Report #5118202-8
OLANZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 13, 2006. Male patient, 35 years of age, was diagnosed with bipolar disorder and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: neuroleptic malignant syndrome. OLANZAPINE dosage: unknown. During the same period patient was treated with ZUCLOPENTHOXOL. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5120578-2
Physician from HUNGARY reported OLANZAPINE problem on Sept 18, 2006. Male patient, 23 years of age, was diagnosed with schizophrenia and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: thrombosis. OLANZAPINE dosage: 5 MG, DAILY (1/D), ORAL. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5120361-8
OLANZAPINE problem was reported by a Physician from PORTUGAL on Sept 21, 2006. Female patient, 60 years of age, was diagnosed with major depression and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: platelet count decreased. OLANZAPINE dosage: 5 MG, DAILY (1/D),. During the same period patient was treated with CLOMIPRAMINE, LORAZEPAM. Patient recovered.
Olanzapine Side Effects Report #5120362-X
Physician from CROATIA (local name: Hrvatska) reported OLANZAPINE problem on Sept 13, 2006. Female patient, 36 years of age, was diagnosed with schizophrenia and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: blood sodium decreased, dehydration, depressed level of consciousness, electroencephalogram abnormal, grand mal convulsion, hyperhidrosis, hypotension. OLANZAPINE dosage: unknown. During the same period patient was treated with FLUPHENAZINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5120369-2
OLANZAPINE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 19, 2006. Male patient, 21 years of age, was diagnosed with bipolar i disorder and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: glomerulosclerosis, pericarditis, pleural effusion, pneumonitis, renal failure chronic. OLANZAPINE dosage: 2.5 MG, DAILY (1/D),. During the same period patient was treated with LITHIUM CARBONATE, VALPROATE, DIPROBASE OINTMENT, LACTULOSE, OILATUM. Patient died on 02/15/2006.
Olanzapine Side Effects Report #5120376-X
Physician from CROATIA (local name: Hrvatska) reported OLANZAPINE problem on Sept 13, 2006. Female patient, 33 years of age, was diagnosed with schizophrenia and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: coma, grand mal convulsion, neuroleptic malignant syndrome, renal failure, rhabdomyolysis, tachycardia, toxicologic test abnormal. OLANZAPINE dosage: 20 MG, DAILY (1/D),ORAL. During the same period patient was treated with FLUFENAZIN. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5120473-9
OLANZAPINE problem was reported by a Consumer or non-health professional from JAPAN on Sept 20, 2006. Female patient, 68 years of age, was diagnosed with schizophrenia and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, schizophrenia, white blood cell count decreased. OLANZAPINE dosage: 5 MG, DAILY (1/D), ORAL. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5120626-X
Consumer or non-health professional from UNITED KINGDOM reported OLANZAPINE problem on Sept 19, 2006. Male patient, 57 years of age, weighting 145.5 lb, was diagnosed with learning disability and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction. OLANZAPINE dosage: 10 MG, ORAL. During the same period patient was treated with CETIRIZINE. Patient died on 07/10/2006.
Olanzapine Side Effects Report #5121036-1
OLANZAPINE problem was reported by a Health Professional from JAPAN on Sept 11, 2006. Female patient, 58 years of age, was diagnosed with schizophrenia, paranoid type and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: polydipsia. OLANZAPINE dosage: 10 MG, DAILY (1/D), ORAL; 15 MG, DAILY (1/D), ORAL; 20 MG, DAILY (1/D), ORAL. During the same period patient was treated with RISPERDAL, CHLORPROMAZINE, TEGRETOL, VEGETAMIN A, NITRAZEPAM, ARTANE. Patient recovered.
Olanzapine Side Effects Report #5123034-0
Pharmacist from UNITED STATES reported OLANZAPINE problem on Oct 04, 2006. Male patient, 56 years of age, weighting 189.6 lb, was diagnosed with schizophrenia and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: blood sodium decreased, grand mal convulsion. OLANZAPINE dosage: 15MG BY MOUTH DAILY. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5123401-5
OLANZAPINE problem was reported by a Health Professional from AUSTRALIA on Sept 25, 2006. Male patient, 58 years of age, was diagnosed with hypomania and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, treatment noncompliance. OLANZAPINE dosage: 20 MG. During the same period patient was treated with CLONAZEPAM, VALPROATE, LITHIUM CARBONATE. Patient died on 08/01/2006.
Olanzapine Side Effects Report #5123410-6
Pharmacist from AUSTRALIA reported OLANZAPINE problem on Sept 18, 2006. Male patient was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, chromosome abnormality, congenital cardiovascular anomaly, congenital cyst, congenital foot malformation, kidney malformation. OLANZAPINE dosage: unknown. Patient died.
Olanzapine Side Effects Report #5123412-X
OLANZAPINE problem was reported by a Pharmacist from JAPAN on Sept 21, 2006. Female patient, 44 years of age, weighting 134.5 lb, was diagnosed with schizophrenia and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: appendicitis, peritonitis, platelet count decreased, sepsis. OLANZAPINE dosage: 10 MG, 2/D, ORAL. During the same period patient was treated with DORAL. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5129127-6
Physician from HUNGARY reported OLANZAPINE problem on Sept 26, 2006. Male patient, 41 years of age, weighting 165.3 lb, was diagnosed with schizophrenia and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: liver function test abnormal. OLANZAPINE dosage: 5 MG, DAILY (1/D), ORAL. Patient recovered.
Olanzapine Side Effects Report #5129146-X
OLANZAPINE problem was reported by a Health Professional from AUSTRALIA on May 25, 2005. Female patient, 66 years of age, weighting 169.8 lb, was diagnosed with psychotic disorder and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: gastrointestinal carcinoma, metastasis. OLANZAPINE dosage: unknown. During the same period patient was treated with VALPROATE. Patient died on 05/22/2005.
Olanzapine Side Effects Report #5129184-7
Physician from TAIWAN, PROVINCE OF CHINA reported OLANZAPINE problem on Sept 22, 2006. Male patient, 23 years of age, was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: bipolar i disorder, delusion of grandeur, insomnia, suicidal ideation, thinking abnormal. OLANZAPINE dosage: 5 MG, DAILY (1/D), ORAL. During the same period patient was treated with DEPAKENE, RIVOTRIL, STILNOX, XANAX, DORMICUM ROCHE. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5129876-X
OLANZAPINE problem was reported by a Physician from HUNGARY on Sept 27, 2006. Female patient, 48 years of age, was diagnosed with schizophrenia and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: atrioventricular block. OLANZAPINE dosage: 5 MG, DAILY (1/D), ORAL. During the same period patient was treated with CLONAZEPAM. Patient recovered.
Olanzapine Side Effects Report #5130057-4
Physician from GREECE reported OLANZAPINE problem on Sept 26, 2006. Female patient, 37 years of age, weighting 158.7 lb, was diagnosed with bipolar disorder, depression and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: electrocardiogram qt prolonged, lipoma of breast. OLANZAPINE dosage: 20 MG, DAILY (1/D), ORAL. During the same period patient was treated with FLUOXETINE HYDROCHLORIDE, MILITHIN, NEURONTIN. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5131636-0
OLANZAPINE problem was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Sept 26, 2006. Male patient, 23 years of age, was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: bipolar i disorder. OLANZAPINE dosage: 5 MG DAILY (1/D) ORAL. During the same period patient was treated with DEPAKENE, RIVOTRIL, STILNOX, XANAX, DORMICUM ROCHE. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5131733-X
Physician from JAPAN reported OLANZAPINE problem on Sept 26, 2006. Female patient, 55 years of age, weighting 84.22 lb, was diagnosed with schizophrenia, paranoid type and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: meige's syndrome. OLANZAPINE dosage: unknown. During the same period patient was treated with RISPERDAL, TASMOLIN, RIVOTRIL, BESACOLIN, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5132396-X
OLANZAPINE problem was reported by a Physician from PORTUGAL on Oct 03, 2006. Female patient, 70 years of age, was diagnosed with major depression and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: petechiae, platelet count decreased. OLANZAPINE dosage: 5 MG, DAILY (1/D), ORAL. During the same period patient was treated with CLOMIPRAMINE, LORAZEPAM, DILTIAZEM, METFORMIN. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5133433-9
Physician from GREECE reported OLANZAPINE problem on Oct 19, 2006. Male patient, 30 years of age, was diagnosed with mild mental retardation and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: intentional overdose, mental disorder, regressive behaviour, somnolence. OLANZAPINE dosage: 10 MG, DAILY (1/D). Patient recovered.
Olanzapine Side Effects Report #5134194-X
OLANZAPINE problem was reported by a Physician from UNITED KINGDOM on Oct 05, 2006. Male patient, 39 years of age, was diagnosed with schizophrenia and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: completed suicide, overdose. OLANZAPINE dosage: unknown. Patient died.
Olanzapine Side Effects Report #5140054-0
Consumer or non-health professional from UNITED STATES reported OLANZAPINE problem on Oct 04, 2006. Male patient, 37 years of age, weighting 246.0 lb, was diagnosed with schizophrenia and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: anal fissure, blood cholesterol increased, blood triglycerides increased, cervicobrachial syndrome, condition aggravated, diabetes mellitus non-insulin-dependent, haemorrhoids, high density lipoprotein decreased, humerus fracture. OLANZAPINE dosage: 10 MG, DAILY (1/D), UNK. During the same period patient was treated with LOTENSIN, DEPAKOTE, PRAVACHOL, RANITIDINE, ZOCOR, VICODIN, FLEXARTAL, NAPROXYN. Patient recovered.
Olanzapine Side Effects Report #5140431-8
OLANZAPINE problem was reported by a Health Professional from BRAZIL on Oct 05, 2006. Male patient, 33 years of age, was diagnosed with schizoaffective disorder and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: anxiety, disease recurrence, insomnia, schizoaffective disorder, suicidal ideation. OLANZAPINE dosage: unknown. During the same period patient was treated with LORAZEPAM. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5140780-3
Health Professional from JAPAN reported OLANZAPINE problem on Oct 06, 2006. Male patient, 57 years of age, weighting 112.4 lb, was diagnosed with schizophrenia, undifferentiated type and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: fall, gastric ulcer, subdural haematoma. OLANZAPINE dosage: 20 MG, DAILY (1/D), ORAL. During the same period patient was treated with VALPROATE, SILECE, DORAL, MAGNESIUM OXIDE. Patient was hospitalized. Patient died on 10/02/2006.
Olanzapine Side Effects Report #5141743-4
OLANZAPINE problem was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Oct 09, 2006. Male patient, 23 years of age, was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: bipolar disorder, condition aggravated. OLANZAPINE dosage: 5 MG DAILY (1/D), ORAL. During the same period patient was treated with DEPAKENE, RIVOTRIL, STILNOX, XANAX, DORMICUM ROCHE. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5141779-3
Physician from HUNGARY reported OLANZAPINE problem on Oct 11, 2006. Female patient, 48 years of age, was diagnosed with schizophrenia and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: atrioventricular block, bradycardia. OLANZAPINE dosage: 5 MG, DAILY (1/D), ORAL. During the same period patient was treated with CLONAZEPAM. Patient recovered.
Olanzapine Side Effects Report #5142770-3
OLANZAPINE problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 13, 2006. Male patient, 28 years of age, weighting 300.0 lb, was diagnosed with schizophrenia and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: biliary tract disorder, cholecystectomy, pancreatitis. OLANZAPINE dosage: unknown. During the same period patient was treated with ABILIFY. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5142789-2
Consumer or non-health professional from UNITED STATES reported OLANZAPINE problem on Oct 13, 2006. Male patient, 74 years of age, weighting 267.9 lb, was diagnosed with abnormal behaviour and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus, diabetic coma, sepsis. OLANZAPINE dosage: 5 MG, ORAL. During the same period patient was treated with HALOPERIDOL. Patient was hospitalized. Patient died on 11/09/2004.
Olanzapine Side Effects Report #5142815-0
OLANZAPINE problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 10, 2006. Male patient, 48 years of age, weighting 285.1 lb, was diagnosed with bipolar disorder and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, blood pressure decreased, cardiac disorder, chest pain, dyspnoea, electrocardiogram t wave abnormal, fatigue, flatulence, full blood count decreased. OLANZAPINE dosage: unknown. During the same period patient was treated with VALPROIC ACID, GUAIFENESIN W, ACETAMINOPHEN, BACTRIM DS. Patient recovered.
Olanzapine Side Effects Report #5143215-X
Health Professional from JAPAN reported OLANZAPINE problem on Oct 15, 2006. Female patient, 21 years of age, weighting 76.28 lb, was diagnosed with schizophrenia, catatonic type and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: ileus paralytic. OLANZAPINE dosage: 2.5 MG, DAILY (1/D), ORAL. During the same period patient was treated with ZYPREXA, HALOPERIDOL, ROHYPNOL, LORAZEPAM. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5141426-0
OLANZAPINE problem was reported by a Pharmacist from UNITED KINGDOM on Oct 20, 2006. Female patient, 23 years of age, was diagnosed with overdose and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: overdose. OLANZAPINE dosage: unknown. During the same period patient was treated with AMISULPRIDE, CLOZARIL. Patient was hospitalized. Patient recovered.
Olanzapine Side Effects Report #5145084-0
Physician from JAPAN reported OLANZAPINE problem on Oct 25, 2006. Female patient, 79 years of age, was diagnosed with schizophrenia, paranoid type, constipation, hypertension and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: choking. OLANZAPINE dosage: 5 MG, 2/D. During the same period patient was treated with MAGLAX. Patient died on 07/31/2006.
Olanzapine Side Effects Report #5148181-9
OLANZAPINE problem was reported by a Physician from UNITED STATES on Oct 26, 2006. Male patient, 38 years of age, was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: mania, psychotic disorder. OLANZAPINE dosage: 10 MG, DAILY (1/D). During the same period patient was treated with LOXAPINE, DIDANOSINE, ZALCITABINE. Patient recovered.
Olanzapine Side Effects Report #5150362-5
Physician from reported OLANZAPINE problem on Aug 30, 2006. Female patient, 28 years of age, weighting 120.0 lb, was diagnosed with conversion disorder, depression, convulsion and was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, hypotension, hypotonia. OLANZAPINE dosage: 5 MG, 2/D. During the same period patient was treated with RIVOTRIL, EPAMIN. Patient died on 08/22/2006.
Olanzapine Side Effects Report #5150367-4
OLANZAPINE problem was reported by a Physician from POLAND on Oct 30, 2006. Female patient, 53 years of age, was treated with OLANZAPINE. After drug was administered, patient experienced the following problems/side effects: electrocardiogram qt prolonged, ventricular fibrillation. OLANZAPINE dosage: unknown. Patient recovered.
Showing 1-100 of 279 Next >
Drug Information: Olanzapine
URL of this page: http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a601213.html
(oh lan' za peen)IMPORTANT WARNING:
| [Posted 05/02/2007] FDA notified healthcare professionals that the Agency proposed that makers of all antidepressant medications update the existing black box warning on the prescribing information for their products to include warnings about the increased risks of suicidal thinking and behavior in young adults ages 18 to 24 years old during the first one to two months of treatment. The proposed labeling changes also state that scientific data did not show this increased risk in adults older than 24 years of age and that adults 65 years of age and older taking antidepressants have a decreased risk of suicidality. The proposed updates apply to the entire category of antidepressants. Individuals currently taking prescribed antidepressant medications should not stop taking them and should notify their healthcare professional if they have concerns. Manufacturers of antidepressant medications will have 30 days to submit their revised product labeling and revised Medication Guides to FDA for review. See the FDA press release for the list of products affected by the proposed antidepressant product labeling changes. For more information visit the FDA website at: http://www.fda.gov/medwatch/safety/2007/safety07.htm#Antidepressant, http://www.fda.gov/bbs/topics/NEWS/2007/NEW01624.html and http://www.fda.gov/cder/drug/antidepressants/default.htm. |
IMPORTANT WARNING:
| Studies have shown that older adults with dementia (a brain disorder that affects the ability to remember, think clearly, communicate, and perform daily activities and that may cause changes in mood and personality) who take antipsychotics (medications for mental illness) such as olanzapine have an increased chance of death during treatment. Older adults with dementia may also have a greater chance of having a stroke or mini-stroke during treatment. If you experience any of the following symptoms, call your doctor immediately: slow or difficult speech, sudden dizziness or faintness, or weakness or numbness of an arm or leg.Olanzapine is not approved by the Food and Drug Administration (FDA) for the treatment of behavior disorders in older adults with dementia. Talk to the doctor who prescribed this medication if you, a family member, or someone you care for has dementia and is taking olanzapine. For more information visit the FDA website: http://www.fda.gov/cder |
Why is this medication prescribed?
Pending revision, the material in this section should be considered in light of more recently available information in the MedWatch notification at the beginning of this monograph.
Olanzapine is used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). It is also used to treat bipolar disorder (manic depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods). Olanzapine is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.
How should this medicine be used?
Olanzapine comes as a tablet and an orally disintegrating tablet (tablet that dissolves quickly in the mouth) to take by mouth. It is usually taken once a day with or without food. Take olanzapine at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take olanzapine exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
Do not try to push the orally disintegrating tablet through the foil. Instead ,use dry hands to peel back the foil packaging. Immediately take out the tablet and place it in your mouth. The tablet will quickly dissolve and can be swallowed with or without liquid.
Your doctor may start you on a low dose of olanzapine and gradually increase your dose.
Olanzapine may help control your symptoms, but it will not cure your condition. It may take several weeks or longer before you feel the full benefit of olanzapine. Continue to take olanzapine even if you feel well. Do not stop taking olanzapine without talking to your doctor. Your doctor will probably want to decrease your dose gradually.
Other uses for this medicine
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
What special precautions should I follow?
Pending revision, the material in this section should be considered in light of more recently available information in the MedWatch notification at the beginning of this monograph.
Before taking olanzapine,
- tell your doctor and pharmacist if you are allergic to olanzapine or any other medications.
- tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: antidepressants; antihistamines; carbamazepine (Tegretol); dopamine agonists such as bromocriptine (Parlodel), cabergoline (Dostinex), levodopa (Dopar, Larodopa), pergolide (Permax), and ropinirole (Requip); fluoroquinolone antibiotics including ciprofloxacin (Cipro), gatifloxacin (Tequin) (not available in the United States), levofloxacin (Levaquin), norfloxacin (Noroxin), ofloxacin (Floxin), others; fluvoxamine (Luvox); ipratropium (Atrovent); medications for anxiety, hypertension, irritable bowel disease, mental illness, motion sickness, Parkinson's disease, seizures, ulcers, or urinary problems; omeprazole (Prilosec); rifampin (Rifadin); sedatives; sleeping pills; ticlopidine (Ticlid); and tranquilizers. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
- tell your doctor if you use or have ever used street drugs or have overused prescription medications and if you have or have ever had a stroke, a mini-stroke, heart disease or a heart attack, an irregular heartbeat, seizures, breast cancer, any condition that makes it difficult for you to swallow, high or low blood pressure, liver or prostate disease, paralytic ileus (condition in which food cannot move through the intestine); or glaucoma (an eye condition), or if you or anyone in your family has or has ever had diabetes. Also tell your doctor if you have ever had to stop taking a medication for mental illness because of severe side effects.
- tell your doctor if you are pregnant or plan to become pregnant. If you become pregnant while taking olanzapine, call your doctor. Do not breast-feed if you are taking olanzapine.
- if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking olanzapine.
- you should know that olanzapine may make you drowsy. Do not drive a car or operate machinery until you know how this medication affects you.
- you should know that alcohol can add to the drowsiness caused by this medication. Do not drink alcohol while taking olanzapine.
- tell your doctor if you use tobacco products. Cigarette smoking may decrease the effectiveness of this medication.
- you should know that you may experience hyperglycemia (increases in your blood sugar) while you are taking this medication, even if you do not already have diabetes. If you have schizophrenia, you are more likely to develop diabetes than people who do not have schizophrenia, and taking olanzapine or similar medications may increase this risk. Tell your doctor immediately if you have any of the following symptoms while you are taking olanzapine: extreme thirst, frequent urination, extreme hunger, blurred vision, or weakness. It is very important to call your doctor as soon as you have any of these symptoms, because high blood sugar can cause a serious condition called ketoacidosis. Ketoacidosis may become life-threatening if it is not treated at an early stage. Symptoms of ketoacidosis include: dry mouth, nausea and vomiting, shortness of breath, breath that smells fruity, and decreased consciousness.
- you should know that olanzapine may cause dizziness, lightheadedness, and fainting when you get up too quickly from a lying position. This is more common when you first start taking olanzapine. To avoid this problem, get out of bed slowly, resting your feet on the floor for a few minutes before standing up.
- you should know that olanzapine may make it harder for your body to cool down when it gets very hot. Tell your doctor if you plan to do vigorous exercise or be exposed to extreme heat.
- if you have phenylketonuria (PKU, an inherited condition in which a special diet must be followed to prevent mental retardation), you should know that the orally disintegrating tablets contain phenylalanine.
What special dietary instructions should I follow?
Talk to your doctor about eating grapefruit and drinking grapefruit juice while taking this medicine.
Be sure to drink plenty of water every day while you are taking this medication.
What should I do if I forget a dose?
Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.
What side effects can this medication cause?
Pending revision, the material in this section should be considered in light of more recently available information in the MedWatch notification at the beginning of this monograph.
Olanzapine may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
- drowsiness
- dizziness
- restlessness
- unusual behavior
- depression
- difficulty falling asleep or staying asleep
- weakness
- difficulty walking
- constipation
- weight gain
- dry mouth
- pain in arms, legs, back, or joints
Some side effects can be serious. If you experience any of the following symptoms or those listed in the IMPORTANT WARNING section or the SPECIAL PRECAUTIONS section, call your doctor immediately:
- seizures
- changes in vision
- swelling of the arms, hands, feet, ankles, or lower legs
- unusual movements of your face or body that you cannot control
- fever
- very stiff muscles
- excess sweating
- fast or irregular heartbeat
- rash
- hives
- difficulty breathing or swallowing
Olanzapine may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online [at http://www.fda.gov/MedWatch/index.html] or by phone [1-800-332-1088].
What storage conditions are needed for this medicine?
Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom). Always store the orally disintegrating tablets in their sealed package, and use them immediately after opening the package. Throw away any medication that is outdated or no longer needed. Talk to your pharmacist about the proper disposal of your medication.
In case of emergency/overdose
In case of overdose, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at 911.
Symptoms of overdose may include:
- drowsiness
- slurred speech
- agitation
- fast heartbeat
- sudden movements that you cannot control
- coma (loss of consciousness for a period of time)
What other information should I know?
Pending revision, the material in this section should be considered in light of more recently available information in the MedWatch notification at the beginning of this monograph.
Keep all appointments with your doctor and the laboratory. Your doctor may order certain lab tests to check your body's response to olanzapine.
Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Brand name(s):
|
|
Brand name(s) of combination products:
|
Ask Our Patient Community about Olanzapine |
||
|
|
||
|
|
||